MARKET

WVE

WVE

Wave Life Scienc
NASDAQ
6.38
-0.04
-0.62%
After Hours: 6.36 -0.02 -0.31% 19:59 05/22 EDT
OPEN
6.40
PREV CLOSE
6.42
HIGH
6.50
LOW
6.29
VOLUME
2.39M
TURNOVER
--
52 WEEK HIGH
21.73
52 WEEK LOW
5.02
MARKET CAP
1.23B
P/E (TTM)
-6.0526
1D
5D
1M
3M
1Y
5Y
1D
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 5/22/26
TipRanks · 23h ago
Weekly Buzz: GH Wins FDA Nod; NMPA Green Lights HCM; MDT To Acquire SPR ; BIIB HALTS BIIB112
NASDAQ · 1d ago
Wave Life Sciences: 'Strong Buy' On DMD NDA Filing WVE-N531 And Released AATD Data
Seeking Alpha · 3d ago
Wave Life Sciences Is Maintained at Overweight by Wells Fargo
Dow Jones · 3d ago
Wells Fargo Maintains Overweight on WAVE Life Sciences, Raises Price Target to $14
Benzinga · 3d ago
Wave Life Sciences price target raised to $14 from $13 at Wells Fargo
TipRanks · 3d ago
Analysts Offer Insights on Healthcare Companies: Relay Therapeutics (RLAY) and Wave Life Sciences (WVE)
TipRanks · 3d ago
Wave Life Sciences Signals Momentum in Earnings Call
TipRanks · 3d ago
More
About WVE
Wave Life Sciences Ltd. is a biotechnology company focused on unlocking the broad potential of ribonucleic acid (RNA) medicines to transform human health. The Company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. The Company's diversified pipeline includes clinical programs in alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease, as well as several preclinical programs utilizing the Company's broad RNA therapeutics toolkit. Its programs include WVE-006, SERPINA1 (AATD); WVE-007 (GalNAc), INHBE (Obesity); WVE-N531, Exon 53 (DMD), and WVE-003, mHTT (HD).

Webull offers Wave Life Sciences Ltd stock information, including NASDAQ: WVE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, WVE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading WVE stock methods without spending real money on the virtual paper trading platform.